Looking for something specific?
At 9M India Limited, trust through quality, transparency, performance.
Anti-Infective Eye Drop Manufacturer in India
WHO-GMP certified sterile manufacturing of anti-infective ophthalmic preparations — antibacterial, antifungal and antiviral eye drops — for bacterial conjunctivitis, fungal keratitis, viral keratitis and post-operative ocular infection prophylaxis.
Key Highlights
-
WHO-GMP
Certified Sterile Ophthalmic Facility -
Sterile Cleanroom
· Grade A/B Manufacturing -
DCGI Approved
Formulations -
Export-Ready
WHAT WE MANUFACTURE
Our Anti-Infective Ophthalmic eye drop range
Our anti-infective ophthalmic range covers the complete spectrum of ocular infections — from common bacterial conjunctivitis to sight-threatening fungal keratitis.
Key molecules manufactured:
- Moxifloxacin 0.5% Eye Drops — Fourth-generation fluoroquinolone, broadest antibacterial spectrum for bacterial conjunctivitis and keratitis
- Ciprofloxacin 0.3% Eye Drops — Second-line fluoroquinolone for bacterial conjunctivitis and corneal ulcers
- Ofloxacin 0.3% Eye Drops — Fluoroquinolone for bacterial conjunctivitis
- Tobramycin 0.3% Eye Drops — Aminoglycoside for gram-negative ocular infections
- Natamycin 5% Eye Drops (Suspension) — The only topical antifungal effective against Fusarium and Aspergillus keratitis — critical in tropical and agricultural communities
- Voriconazole 1% Eye Drops — For Aspergillus and Candida fungal keratitis
- Ganciclovir 0.15% Eye Gel — For herpetic keratitis (HSV)
- Acyclovir 3% Eye Ointment
Enquire Now
WHY 9M INDIA
Anti-infective ophthalmic manufacturing — from standard antibiotics to specialty Natamycin suspension
-
Sterile ophthalmic manufacturing — classified cleanroom
All ophthalmic preparations at 9M India are manufactured in dedicated sterile cleanroom environments — Grade A fill-finish under Class A laminar airflow, with Grade B background. Environmental monitoring, water for injection (WFI) system validation, 0.22 micron sterile filtration and 100% container closure integrity testing are standard on every batch. No ophthalmic product is manufactured outside these conditions.
-
In-house ophthalmic QC — specialised testing
Sterility · Bacterial endotoxins · Visible particulate matter · Sub-visible particles · pH · Osmolality · Assay (HPLC) · Preservative content · Container closure integrity — all tested in our dedicated ophthalmic QC laboratory. COA issued per batch.
-
Complete documentation within 24 hours
DCGI manufacturing licence · WHO-GMP Certificate · COA · COC · Stability data (ICH Zone II and IVa) · Compatibility studies — available within 24 hours for tender, export registration or CDMO requirements.
WHO WE SUPPLY
Who sources anti-infective ophthalmic eye drops from 9M India
-
Ophthalmology departments & eye hospitals
Ophthalmology departments in government and private hospitals, eye hospitals, district health centres — anti-infective eye drops are among the highest-frequency ophthalmic prescriptions in both primary and tertiary care.
-
Private label & contract manufacturing partners
Domestic ophthalmic brands manufacturing anti-infective eye drops through 9M India — Natamycin 5% suspension is a particularly high-value specialty formulation with significant demand in markets with high fungal keratitis burden.
-
International export buyers
African export buyers specifically — Natamycin 5% eye drops for fungal keratitis is among the highest-demand ophthalmic products in East and West Africa where fungal keratitis is endemic. 9M India already supplies this through African export partnerships.
Need WHO-GMP anti-infective eye drops manufactured under your brand?
Share your requirement — molecule, concentration, pack size and target market. We confirm manufacturing capability, documentation and lead times within 24 hours.
-
WHO-GMP
Certified Facility -
In-House QC
-
Contract &
3PM Available -
DCGI
Approved
Ophthalmic categories
Ophthalmic formulations across 11 categories
We keep answer short
Frequently Asked Questions
Find answers to the most common questions about our products, services, pricing, and policies.
-
01
Yes. 9M India manufactures ophthalmic anti-infective eye drops — including Moxifloxacin, Ciprofloxacin, Tobramycin, Gentamicin, Chloramphenicol, Acyclovir and Natamycin — at its WHO-GMP certified sterile ophthalmic facility in Birkoni, Chhattisgarh. All formulations are produced in classified cleanroom environments with aseptic fill-finish and sterility testing on every batch.
-
02
9M India manufactures a comprehensive range of antibiotic eye drops including Moxifloxacin 0.5% (fluoroquinolone — broad-spectrum), Ciprofloxacin 0.3% (fluoroquinolone), Tobramycin 0.3% (aminoglycoside), Gentamicin 0.3% (aminoglycoside), Chloramphenicol 0.5% (broad-spectrum), Norfloxacin 0.3% and Gatifloxacin 0.3%. All are available for institutional and export supply.
-
03
Yes. 9M India manufactures Natamycin 5% ophthalmic suspension — the only topical antifungal approved for fungal keratitis treatment. Natamycin eye drops are in particularly high demand in Africa and South Asia where fungal corneal infections are prevalent due to agricultural occupational exposure and tropical climate. This is a specialty formulation not produced by most ophthalmic manufacturers.
-
04
9M India manufactures Acyclovir (Aciclovir) ophthalmic ointment/drops for herpes simplex keratitis — one of the most common causes of infectious blindness globally. Acyclovir ophthalmic formulations are essential medicines in ophthalmology departments across all our export markets and are supported by full GMP documentation for institutional supply.
-
05
Yes. 9M India manufactures several combination ophthalmic formulations including Ciprofloxacin + Dexamethasone, Gentamicin + Dexamethasone, Tobramycin + Dexamethasone and Moxifloxacin + Prednisolone. These combinations address both infection and inflammation simultaneously — widely used post-operative and in bacterial conjunctivitis with significant inflammatory component.
-
06
All ophthalmic anti-infective eye drops are manufactured to full sterile pharmaceutical standards: classified cleanroom (Grade A/B aseptic fill zone), WFI on-site, 0.2 micron sterile filtration, compendial sterility testing (every batch), particulate matter analysis (USP <788>), pH, osmolality and assay testing. These standards are documented in the batch CoA provided with every shipment.
-
07
9M India exports ophthalmic anti-infective eye drops to 15+ countries across Phase 1 markets including the UAE, Iraq, Egypt, Mexico, Russia, Kazakhstan, Sri Lanka and others in the Middle East, CIS, Africa and ASEAN. Eye infections — particularly bacterial conjunctivitis — are among the most common ophthalmic presentations in all these markets, creating consistent high-volume demand.
-
08
Documentation available includes WHO-GMP Certificate, DCGI Manufacturing Licence, Certificate of Pharmaceutical Product (CoPP), batch-wise Certificate of Analysis (sterility, particulate matter, pH, assay, preservative content), ICH Zone IVb stability data and CTD/ACTD dossiers on request. Multi-lingual labelling is available for destination market regulatory requirements.
